Zacks Investment Management bought a new stake in LHC Group, Inc. (NASDAQ:LHCG) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 41,179 shares of the health services provider’s stock, valued at approximately $3,525,000. Zacks Investment Management owned 0.13% of LHC Group as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SG Americas Securities LLC bought a new stake in shares of LHC Group in the first quarter valued at about $105,000. Envestnet Asset Management Inc. bought a new position in LHC Group during the first quarter worth about $134,000. Cubist Systematic Strategies LLC lifted its stake in LHC Group by 36.9% during the first quarter. Cubist Systematic Strategies LLC now owns 2,636 shares of the health services provider’s stock worth $162,000 after purchasing an additional 711 shares during the period. Bank of Montreal Can lifted its stake in LHC Group by 251.9% during the second quarter. Bank of Montreal Can now owns 2,481 shares of the health services provider’s stock worth $212,000 after purchasing an additional 1,776 shares during the period. Finally, M&T Bank Corp bought a new position in LHC Group during the first quarter worth about $228,000. Institutional investors and hedge funds own 87.05% of the company’s stock.

NASDAQ LHCG opened at $95.11 on Thursday. The company has a market cap of $3.03 billion, a PE ratio of 39.30, a PEG ratio of 1.52 and a beta of 0.52. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.59 and a quick ratio of 1.59. LHC Group, Inc. has a 1-year low of $58.65 and a 1-year high of $100.90.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, August 1st. The health services provider reported $0.84 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.06. The company had revenue of $502.00 million during the quarter, compared to analyst estimates of $509.03 million. LHC Group had a net margin of 3.75% and a return on equity of 8.33%. The company’s revenue was up 95.0% on a year-over-year basis. During the same quarter last year, the business posted $0.63 earnings per share. equities analysts predict that LHC Group, Inc. will post 3.52 earnings per share for the current year.

A number of brokerages have commented on LHCG. Cantor Fitzgerald began coverage on shares of LHC Group in a research note on Wednesday. They set an “overweight” rating for the company. BidaskClub upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a research note on Thursday, August 16th. Royal Bank of Canada raised their price target on shares of LHC Group to $101.00 and gave the stock a “sector perform” rating in a research note on Friday, August 3rd. Jefferies Financial Group raised their price target on shares of LHC Group to $120.00 and gave the stock a “buy” rating in a research note on Friday, August 3rd. Finally, Zacks Investment Research upgraded shares of LHC Group from a “sell” rating to a “hold” rating and set a $104.00 price target for the company in a research note on Saturday, August 4th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $93.89.

In other news, COO Donald Dwayne Stelly sold 2,756 shares of the firm’s stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $99.32, for a total transaction of $273,725.92. Following the completion of the sale, the chief operating officer now owns 104,512 shares of the company’s stock, valued at $10,380,131.84. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Jeff Reibel sold 1,921 shares of the firm’s stock in a transaction that occurred on Monday, August 20th. The stock was sold at an average price of $94.12, for a total transaction of $180,804.52. Following the sale, the senior vice president now directly owns 8,125 shares of the company’s stock, valued at approximately $764,725. The disclosure for this sale can be found here. Company insiders own 6.80% of the company’s stock.

LHC Group Profile

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Featured Story: How to Profit and Limit Losses With Stop Orders

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.